Reductions in Management Distress Following a Randomized Distress Intervention Are Associated With Improved Diabetes Behavioral and Glycemic Outcomes Over Time

Danielle Hessler, Lisa Strycker, Lawrence Fisher, Danielle Hessler, Lisa Strycker, Lawrence Fisher

Abstract

Objective: To explore associations between reductions in diabetes distress (DD) and improvements in glycemic outcomes among adults with type 1 diabetes (T1D) in the context of a DD randomized clinical trial.

Research design and methods: Adults with T1D (N = 301) participated in a two-arm trial aimed at reducing DD (DD-focused OnTrack group vs. education-oriented KnowIt group). Mean age was 45.1 years; mean baseline HbA1c was 8.8% (73 mmol/mol). Individuals were assessed at baseline and 9 months later on DD, self-care, HbA1c, and frequency of hypoglycemia. Structural equation models evaluated hypothesized pathways among changes in DD, self-care, and glycemic outcomes in the total sample and by intervention group.

Results: Reductions in DD were significantly and independently associated with better self-care, including fewer missed insulin boluses, more frequent insulin adjustment, improved problem-solving skills, more blood glucose monitoring, and greater adoption of continuous glucose monitoring (all P < 0.05). In turn, better self-care was linked with better glycemic outcomes, including fewer episodes of hypoglycemia and improved HbA1c over time. Fit indices indicated good fit of the model to the data (confirmatory fit index = 0.94, root mean square error of approximation = 0.05), with stronger and more meaningful associations for OnTrack than for KnowIt.

Conclusions: In the context of an intervention to reduce DD for adults with T1D, results indicate that reductions in DD do not affect glycemic outcomes directly but through improvements in self-care behavior. Findings support the importance of integrating disease management with DD interventions to maximize improvements in glycemic outcomes.

Trial registration: ClinicalTrials.gov NCT02175732.

© 2021 by the American Diabetes Association.

Figures

Figure 1
Figure 1
Measurement model. BG, blood glucose.
Figure 2
Figure 2
Significant structural equation modeling pathways linking change in management distress with change in glycemic outcomes in the final model. Linkages shown are significant pathways (P < 0.05) (see Table 2) in the final model. All pathways denoted here reached statistical significance for the OnTrack and KnowIt groups, with the exception of pathways from problem solving and diabetes knowledge to hypoglycemia episodes for the KnowIt group (P > 0.05). Further variations in strength of associations by intervention group are presented in Table 2. BG, blood glucose.

References

    1. Fisher L, Skaff MM, Mullan JT, et al. . Clinical depression versus distress among patients with type 2 diabetes: not just a question of semantics. Diabetes Care 2007;30:542–548
    1. Fisher L, Polonsky WH, Hessler DM, et al. . Understanding the sources of diabetes distress in adults with type 1 diabetes. J Diabetes Complications 2015;29:572–577
    1. Fisher L, Hessler D, Polonsky W, et al. . Emotion regulation contributes to the development of diabetes distress among adults with type 1 diabetes. Patient Educ Couns 2018;101:124–131
    1. van Bastelaar KM, Pouwer F, Geelhoed-Duijvestijn PH, et al. . Diabetes-specific emotional distress mediates the association between depressive symptoms and glycaemic control in type 1 and type 2 diabetes. Diabet Med 2010;27:798–803
    1. Strandberg RB, Graue M, Wentzel-Larsen T, Peyrot M, Rokne B. Relationships of diabetes-specific emotional distress, depression, anxiety, and overall well-being with HbA1c in adult persons with type 1 diabetes. J Psychosom Res 2014;77:174–179
    1. Joensen LE, Tapager I, Willaing I. Diabetes distress in type 1 diabetes--a new measurement fit for purpose. Diabet Med 2013;30:1132–1139
    1. Hessler DM, Fisher L, Polonsky WH, et al. . Diabetes distress is linked with worsening diabetes management over time in adults with type 1 diabetes. Diabet Med 2017;34:1228–1234
    1. Hessler D, Fisher L, Glasgow RE, et al. . Reductions in regimen distress are associated with improved management and glycemic control over time. Diabetes Care 2014;37:617–624
    1. Aikens JE. Prospective associations between emotional distress and poor outcomes in type 2 diabetes. Diabetes Care 2012;35:2472–2478
    1. Al Sayah F, Yeung RO, Johnson JA. Association of depressive symptoms and diabetes distress with severe hypoglycemia in adults with type 2 diabetes. Can J Diabetes 2019;43:316–321
    1. Al Hayek AA, Robert AA, Al Dawish MA. Effectiveness of the FreeStyle Libre flash glucose monitoring system on diabetes distress among individuals with type 1 diabetes: a prospective study. Diabetes Ther 2020;11:927–937
    1. Polonsky WH, Hessler D, Ruedy KJ; DIAMOND Study Group . The impact of continuous glucose monitoring on markers of quality of life in adults with type 1 diabetes: further findings from the DIAMOND randomized clinical trial. Diabetes Care 2017;40:736–741
    1. Fredrickson BL, Branigan C. Positive emotions broaden the scope of attention and thought-action repertoires. Cogn Emotion 2005;19:313–332
    1. Reich J, Zautra A, Davis M. Dimensions of affect relationships: Models and their integrative implications. Rev Gen Psychol 2003;7:66–83
    1. Fisher L, Hessler D, Polonsky WH, et al. . T1-REDEEM: a randomized controlled trial to reduce diabetes distress among adults with type 1 diabetes. Diabetes Care 2018;41:1862–1869
    1. Funnell MM, Tang TS, Anderson RM. From DSME to DSMS: developing empowerment-based diabetes self-management support. Diabetes Spectr 2007;20:221–226
    1. Madmoli M. A systematic review study on the results of empowerment-based interventions in diabetic patients. Int Res Med and Health Sci 2019;2:1–7
    1. Rollnick S, Allison J. Motivational interviewing. In The Essential Handbook of Treatment and Prevention of Alcohol Problems. Heather N, Stockwell T, Eds. Chichester, U.K., Wiley, 2004, pp. 105–116
    1. Miller WR, Rollnick S. Motivational Interviewing: Helping People Change. New York, Guilford Press, 2012
    1. Fisher L, Hessler D, Polonsky W, Strycker L, Masharani U, Peters A. Diabetes distress in adults with type 1 diabetes: prevalence, incidence and change over time. J Diabetes Complications 2016;30:1123–1128
    1. Fitzgerald JT, Funnell MM, Anderson RM, Nwankwo R, Stansfield RB, Piatt GA. Validation of the Revised Brief Diabetes Knowledge Test (DKT2). Diabetes Educ 2016;42:178–187
    1. Hill-Briggs F, Yeh HC, Gary TL, Batts-Turner M, D’Zurilla T, Brancati FL. Diabetes problem-solving scale development in an adult, African American sample. Diabetes Educ 2007;33:291–299
    1. Sturt J, Dennick K, Hessler D, Hunter BM, Oliver J, Fisher L. Effective interventions for reducing diabetes distress: systematic review and meta-analysis. Int Diabetes Nurs 2015;12:40–55
    1. Schmidt CB, van Loon BJP, Vergouwen ACM, Snoek FJ, Honig A. Systematic review and meta-analysis of psychological interventions in people with diabetes and elevated diabetes-distress. Diabet Med 2018;35:1157–1172
    1. Fisher L, Hessler D, Glasgow RE, et al. . REDEEM: a pragmatic trial to reduce diabetes distress. Diabetes Care 2013;36:2551–2558
    1. Muthén LK, Muthén BO. Mplus user’s guide (6th ed.). Los Angeles, Muthén & Muthén, 2011
    1. Duncan TE, Duncan SC, Strycker LA. An Introduction to Latent Variable Growth Curve Modeling: Concepts, Issues, and Applications. 2nd ed. Mahwah, NJ, Lawrence Erlbaum, 2006, pp. 81–92
    1. Fisher L, Polonsky WH, Hessler D. Addressing diabetes distress in clinical care: a practical guide. Diabet Med 2019;36:803–812
    1. Skinner TC, Joensen L, Parkin T. Twenty-five years of diabetes distress research. Diabet Med 2020;37:393–400
    1. Shumway M, Fisher L, Hessler D, Bowyer V, Polonsky WH, Masharani U. Economic costs of implementing group interventions to reduce diabetes distress in adults with type 1 diabetes mellitus in the T1-REDEEM trial. J Diabetes Complications 2019;33:107416.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi